Gender gap in pharmacological reperfusion and outcomes of ST-elevation acute myocardial infarction: Paraguayan cohort 2019–2023.
DOI:
https://doi.org/10.52379/mcs.v9.701Keywords:
Myocardial infarction, Reperfusion, Gender equityAbstract
Introduction: ST-elevation acute myocardial infarction (STEMI) is one of the leading causes of cardiovascular morbidity and mortality. Early reperfusion, mainly through fibrinolysis in developing countries, is essential to reduce complications and mortality. However, multiple international registries have documented gender inequities in access to reperfusion therapies, with greater delays and worse outcomes in women. In Paraguay, where fibrinolysis remains the most widely used strategy under the IAM Code, there had been no national analysis to assess these differences. Objective: To assess the gender gap in pharmacological reperfusion and in-hospital outcomes in patients with STEMI in Paraguay between 2019 and 2023. Methodology: Observational, retrospective, multicenter study based on the national registry of the IAM Code. Consecutive patients with acute coronary syndrome were included. Clinical characteristics, risk factors, reperfusion strategies, critical times, and in-hospital outcomes were analyzed using ?² and Mann–Whitney U tests, with significance set at p<0.05. Results: A total of 1,831 patients were included. Women were older (65.6 ± 12.4 vs. 60.3 ± 11.4 years; p<0.001) and had more hypertension, diabetes, and obesity, while smoking and alcohol consumption were more common in men. Fibrinolysis was performed in 64.1% of patients, less frequently in women than in men (61.1% vs. 66.2%; p=0.048). Critical times were longer in women: symptom-to-door (310 vs. 280 min), door-to-needle (50 vs. 40 min), and total ischemia (370 vs. 340 min; p<0.001). In-hospital mortality was higher in women (12.4% vs. 7.8%; p<0.001), as was heart failure (15.2% vs. 10.5%; p=0.01), while no significant sex differences were found in ventricular arrhythmias, stroke, or major bleeding. Conclusion: Women with STEMI in Paraguay have lower access to fibrinolysis, longer treatment delays, and worse in-hospital outcomes, confirming persistent gender inequities that require targeted health strategies.Downloads
References
1. GBD 2019 Diseases and Injuries Collaborators. Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis. Lancet. 2020;396(10258):1204-22. https://www-sciencedirect-com.americana.idm.oclc.org/science/article/pii/S0140673620309259?via%3Dihub
2. Vedanthan R, Seligman B, Fuster V. Global perspective on acute coronary syndrome: a burden on the young and poor. Circ Res. 2014;114(12):1959–75. https://doi.org/10.1161/CIRCRESAHA.114.30278
3. Ibanez B, James S, Agewall S, Antunes MJ, Bucciarelli-Ducci C, Bueno H, et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J. 2018;39(2):119–77. https://doi.org/10.1093/eurheartj/ehx393
4. D’Onofrio G, Safdar B, Lichtman JH, Strait KM, Dreyer RP, Geda M, et al. Sex differences in reperfusion in young patients with ST-segment–elevation myocardial infarction: results from the VIRGO study. Circulation. 2015;131(15):1324–32. https://doi.org/10.1161/circulationaha.114.012293
5. Oliveira C, Vilela F, Flores R, Medeiros P, Pires C, Mane F, et al. ST-segment elevation myocardial infarction: are women being discriminated? Eur Heart J. 2021;42(Suppl 1):ehab724.2789. https://doi.org/10.1093/eurheartj/ehab724.2789
6. Gupta A, Barrabés JA, Strait KM, Bueno H, Porta‐Sánchez A, Acosta-Vélez J, et al. Sex differences in timeliness of reperfusion in young patients with ST‐segment elevation myocardial infarction by initial electrocardiographic characteristics. J Am Heart Assoc. 2018;7(22):e007021. https://doi.org/10.1161/jaha.117.007021
7. Leurent G, Garlantézec R, Auffret V, Hacot JP, Coudert I, Filippi E, et al. Gender differences in presentation, management and in-hospital outcome in patients with STEMI: data from 5000 patients in the ORBI French registry. Arch Cardiovasc Dis. 2014;107(5):291–8. https://doi.org/10.1016/j.acvd.2014.04.005
8. Oliveira C, Vilela F, Braga C, Costa J, Marques J. ST-segment elevation myocardial infarction differences between genders: a single center retrospective analysis. Arq Bras Cardiol. 2023;120(1):e20211040. https://doi.org/10.36660/abc.20211040
9. Cook S, Allemann L, Cook M, Arroyo D, Pittet T, Meier P, et al. Sex differences in STEMI patients treated by primary PCI. Open Heart. 2025;12:e002831. https://doi.org/10.1136/openhrt-2024-002831
10. González G, Fernández F, Ávalos D, Ortellado J, Adorno M, Galeano J, et al. Registro Nacional de Síndrome Coronario Agudo en Paraguay (RENASCA-PY). Arch Cardiol Mex. 2022;92(2):174–80. https://doi.org/10.24875/acm.20000489
11. Collet JP, Thiele H, Barbato E, Barthélémy O, Bauersachs J, Bhatt DL, et al. 2023 ESC Guidelines for the management of acute coronary syndromes. Eur Heart J. 2023;44(38):3720–3826. https://doi.org/10.1093/eurheartj/ehad191
12. Lawton JS, Tamis-Holland JE, Bangalore S, Bates ER, Beckie TM, Bischoff JM, et al. 2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization. J Am Coll Cardiol. 2022;79(2):e21–e129. https://doi.org/10.1016/j.jacc.2021.09.006
13. Zhao L, Guo A, Sun B, Li P, Wang Z, Li L, et al. Sex differences in STEMI management and outcomes: a retrospective analysis from the China Chest Pain Center Database. Cardiol Plus. 2024;9(3):159–67. http://dx.doi.org/10.1097/cp9.0000000000000095
14. Juan-Salvadores P, Castro-Rodríguez M, Jiménez-Díaz VA, Veiga C, Busto L, Fernández-Barbeira S, et al. Sex differences in delay times in ST-segment elevation myocardial infarction: a cohort study. Med Clin (Barc). 2024;163(3):115–20. https://doi.org/10.1016/j.medcli.2024.02.015
15. De Luca G, Manzo Silberman S, et al. Gender difference in mechanical reperfusion and 30-day mortality for STEMI: ISACS-STEMI COVID-19 Registry. J Clin Med. 2023;12(3):896. https://doi.org/10.3390/jcm12030896
16. Elbarbary M, Gad M, Awad H, et al. Gender disparities in presentation, management, and outcomes of ACS in Egypt. BMC Cardiovasc Disord. 2024;24:77. https://doi.org/10.1186/s12872-024-03996-8
17. Mousavi RA, Piker L, Rezai M. Sex differences in management of acute coronary syndromes: current evidence. Wien Klin Wochenschr. 2023;135(5–6):127–36. https://doi.org/10.1007/s00508-023-02302-4
18. Das MK, Malviya A, Zachariah G, Ramakrishnan S, Jabir A, Nair VK, et al. Gender bias in acute myocardial infarction care in India: nationwide retrospective study of 41,832 patients. Indian Heart J. 2025;77(1):22–7. https://doi.org/10.1016/j.ihj.2025.01.001
19. Medzikovic L, Azem T, Sun W, Rejali P, Esdin L, Rahman S, et al. Sex Differences in Therapies against Myocardial Ischemia-Reperfusion Injury: From Basic Science to Clinical Perspectives. Cells. 2023;12(16):2077. https://doi.org/10.3390/cells12162077
20. Cenko E, Manfrini O, Yoon J, van der Schaar M, Bergami M, Vasiljevic Z, et al. Sex differences in heart failure following acute coronary syndromes. JACC Adv. 2023;2(5):100294. https://doi.org/10.1016/j.jacadv.2023.100294
21. Pana TA, Mamas MA, Myint PK, Dawson DK. Sex differences in myocardial infarction care and outcomes: a longitudinal Scottish national data-linkage study. Eur J Prev Cardiol. 2025;32(8):696–707. https://doi.org/10.1093/eurjpc/zwae333
22. Marzà-Florensa A, Kiss P, Youssef DM, Jalali-Farahani S, Lanas F, Di Cesare M, et al. Sex differences in acute coronary syndromes: a scoping review across the care continuum. Glob Heart. 2025;20(1):26. https://pmc.ncbi.nlm.nih.gov/articles/PMC11908429/
23. Holtzman JN, Kaur G, Hansen B, Bushana N, Gulati M. Sex differences in the management of atherosclerotic cardiovascular disease. Atherosclerosis. 2023;384:117268. https://doi.org/10.1016/j.atherosclerosis.2023.117268
24. Stehli J, Dinh D, Dagan M, Duffy SJ, Brennan A, Smith K, et al. Sex differences in prehospital delays in patients with ST-segment–elevation myocardial infarction undergoing percutaneous coronary intervention. J Am Heart Assoc. 2021;10(13):e019938. https://doi.org/10.1161/JAHA.120.019938
25. Motovska Z, Hlinomaz O, Aschermann M, Jarkovsky J, Želízko M, Kala P, et al. Trends in outcomes of women with myocardial infarction undergoing primary angioplasty—analysis of randomized trials. Front Cardiovasc Med. 2023;9:953567. https://doi.org/10.3389/fcvm.2022.953567
26. Knox ECL, Mateo-Rodríguez I, Daponte-Codina A, Rosell-Ortiz F, Solá-Muñoz S, Codina-Rodríguez A, et al. Gender differences in clinical practice regarding coronary heart disease: a systematic review. J Clin Med. 2025;14(5):1583. https://doi.org/10.3390/jcm14051583
27. Vogel B, Chieffo A, Figtree GA, Bairey Merz CN, Reynolds HR, Kunadian V, et al. The Lancet women and cardiovascular disease Commission: reducing the global burden by 2030. Lancet. 2021;397(10292):2385–438. https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)00684-X/abstract
28. Widimsky P, Wijns W, Fajadet J, de Belder M, Knot J, Aaberge L, et al. Reperfusion therapy for ST-elevation acute myocardial infarction in Europe: description of the current situation in 30 countries. Eur Heart J. 2010;31(8):943–57. https://doi.org/10.1093/eurheartj/ehp492
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Dr. José Ortellado Maidana, Graciela González, Gabriel Gaona Figueredo, MSc. Dr. Ángel R. Rolón Ruiz Díaz, Marta Ferreira Gaona
This work is licensed under a Creative Commons Attribution 4.0 International License.
